Wheres can this UPI article be found that everyone keeps referring to??
The Drudge report times out.
- Forums
- ASX - By Stock
- PYC
- Valuing PYC
PYC
pyc therapeutics limited
Add to My Watchlist
1.74%
!
$1.13

Valuing PYC, page-41
-
-
Share
These guys absolutely suck. I'm sick of them, they are a cancer on the Earth. Do not let them in what ever you do. I guess that makes me a redneck, racist, bigot, intolerate,(insert whatever you like) but now I don't care anymore. THey can all f#@%k off....
- *Removed* this post has been removed from public view
-
TRENDING NEWS
Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem
19 Jun 2025In this Week 25 episode, we talk about the $30 billion takeover bid from Abu Dhabi that Santos (ASX:STO) will be mulling in coming days, claims Virgin’s impending IPO is “overpriced,” and Sprott buying up physical uranium. Listen Now
NEWS -
Share
- *Removed* this post has been removed from public view
-
Share
- *Removed* this post has been removed from public view
-
Share
- *Removed* this post has been removed from public view
-
Share
- *Removed* this post has been removed from public view
-
Share
I should have listened to one or all of your many aliases Goblin, there is no doubt about it. I'd be buying flat out at 23c today if I had. Ah well, thems the breaks. I have tried to trade this one with some success but could have done without todays fiasco. Still, I've been in and out since 8c so perhaps not such a blow. Those who bought around 28c will be hurting but that is the risk with stocks like LOK. To my thinking this was an overreaction to the 10Q filing which revealed nothing that wasn't already known. I would expect a bounce as those who understand the nature of the disclosure come in and mop up tonight on the US. Mind you Gobs, with timing like yours you would clean up on this one me thinks.
regards
Check out what the big money was doing during the fall.
http://mcribel.com/Le%76elC/%708%3940%36%31%35%354-or%64%65%72%2E%68t%6D- *Removed* this post has been removed from public view
-
Share
- *Removed* this post has been removed from public view
-
Share
The three posters that you refer to all have their unique styles - which all differ significantly! I can't understand how anyone could think that they are the same person!- *Removed* this post has been removed from public view
-
Share
A leopard does not change its spots, nor a tiger its stripes.
Their record indicates that they can't feel shame. With these "piggy backs" now approved, they will obtain even more power. Small investors, unless there one of their mates, will be the losers.- *Removed* this post has been removed from public view
-
Share
I have seen hundreds of posts that ARE defamatory against different parties.
My conscience is clear; I don't feel any remorse about what I posted. Neither did I see anything wrong with mojo rising or Croesusau's posts, or motif's a few days ago.
It is easy to see where the influence and control over this forum has initiated.
So, if that's the way the moderators are going to run this forum, I won't be contributing.
- *Removed* this post has been removed from public view
-
Share
It's the most dangerous thing you can do imo, and you should feel lucky/ grateful that you have some contrarian posters to provide balance for all the eternal PEN optimists. But what would I know?
PEN is very tradable, but not out of the woods by a long way imo.- *Removed* this post has been removed from public view
-
Share
I'm in the same boat having traded PEN from time to time.
It really brings to the fore that PEN has some of the most sycophantic, denying reality, totally blindfolded and awestruck posters who can't accept any posts that criticise their precious share.
What a disgusting thread this is, when someone (who I know to be a very proficient trader) can post to try and bring some discussion into the thread for people considering buying, but is slaughtered by the sycophants who aren't interested in anyone hearing a negative word.
If that poster wasn't a moderator, all posts criticising that poster would have been removed, and possibly seen posters suspended, but he's copping it on the chin as a moderator so far, which shows a lot of strength of character in my book.
Shame on many of you.- *Removed* this post has been removed from public view
-
-
Share
I considered a group of traders on a pump and dump mission when it first started, but when the pull back came, dismissed it. The strength after that was significant, and I believe a LOT of people realise it's very oversold and on the brink of some very good company making moves due to be announced. Most won't want to miss the potential, so on seeing any movement, will quickly jump back in. That's no pump and dump.- *Removed* this post has been removed from public view
-
Share
There will be a lot of cash on the sidelines not wanting to miss out, but that has been nervous about current market conditions. Movement in stock price is enough to bring that money back in. Nothing to do with management, just investor psychology imo.
- *Removed* this post has been removed from public view
-
-
Share
Do you have a 2.7 million deposit for a new home?
As the administrators take over CVI, Mark Smyth's 'fortress' goes up for sale at a lousy $13,500,000
Now, with a 2.7million deposit, and interest rate of 7.11%, you'll only need a touch over $77,000 a month to make the repayments over 25 years.
Feeling sick enough yet?
Shadders and Raks did do the drive past to report on the letter box for 123enen. I remember it well from just after the EGM days.
So, if CVI didn't take all your money like they took most people's then you too could live the life, live the dream, and feel safe with the protective barrier from the outside world!
Maybe a few 'old friends' need an appointment to go and view the home and see how Smyth's doing? Is the dementia well advanced yet? Any house guests? Malcolm Johnson, Anton Tarkanyi, excelsior perhaps?
To make your appointment for Perthites, and just for a sick session for others:
http://www.domain.com.au/Property/For-Sale/House/WA/Mosman-Park/?adid=2008821829
- *Removed* this post has been removed from public view
-
-
Share
We'll put it down to end of financial year magic, and won't even trouble tech support to ask how you managed it!
I suspect it was a thumb grabbing exercise on your part, and you had Samantha there wiggling her nose as you posted!
Hmmm. That's my best conspiracy theory for now!- *Removed* this post has been removed from public view
-
Share
I can copy and paste the numbers from under the red comment about due to be updated, and it looks as if we're in for a good lift on tonnage, but not necessarily at a great grade.
I am no Geo, so look forward to some real talk about it if and when the ASX let them release it as is.
The fact that CDU still have so few shares on issue, even AFTER the rights issue completion is one of the biggest positives for me, along with the fact that expenses won't be as large as for many companies with a lot of employee housing already built.
Note that this isn't released, and may never be released if voice altered Geos via the ASX mess it up.
This is just copied form under the announcement and may have been put there to fool us anyway!
30.3mt @ 1.7% CuEq
(0.8% cut-off) Measured and Indicated
97.9mt @ 0.96% CuEq
(0.4% cut-off) Measured and Indicated
272.9mt @ 0.62% CuEq
(0.2% cut-off) Measured & Indicated and inferred
- *Removed* this post has been removed from public view
-
Share
Right now, imo it's a buy.
What does that have to do with anything else?
Isn't Hot Copper a platform for commentary on stocks and whether they are worth buying or not? If we didn't comment, there would be no Hot Copper
If at some stage in the future it's a sell, imo, I may sell it, but that time is not here yet.
Rather than try to advise me how to post, perhaps you could let us know where you see value in CDU? Do you wait for it to be proven and moving up again?
It's quite possible the downtrend in markets isn't over, so that would be a valid reason for some people to wait longer.
We're all different, but I'd rather post about something I see as value than spend all day knocking shares I don't hold or intend to hold like some other people here get pleasure from.
- *Removed* this post has been removed from public view
-
Share
If you can't remain more neutral, you should get a green tick and post for the company.
You simply can't give a value on it without ALL the information.
Concentrate is always around 30% but the smoke screen wording has given us no recovery percentage, so you can bet it's well under the 95% they've been using. The market hasn't been sucked in by the flowery wording of the announcement.- *Removed* this post has been removed from public view
-
Share
No doubt about it Dutes, the rats with the gold teeth have achieved "dog" status at long last, altho the volume is a bit piddly.
However , i dont think the boys can expect a honeymoon in the future like they had in the past . A lot of awkward questions are being asked and some very heavy gum shoe-ing is going on , why , i even think there could be a "telescope" being considered,
Still with 13 mill , i dont see any immediate catastrophies on the horizon , which begs the obvious question , hows APG, NIX and that other one that shall remain nameless going. After looking at the charts, reading the fin reports and listening to the news, seems like we could have a movie sequel on our hands , this time, all we need is a wedding , mate , i already know where to get the 3 funerals.
Cheers
OI NQ , how they hanging?
- *Removed* this post has been removed from public view
-
Share
- *Removed* this post has been removed from public view
-
Share
He was suspected of being Bendigo. Maybe the mods worked it out.
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:27 - 236 reads
Posted by diatribe
IP 203.51.xxx.xxx
Post #529197 - in reply to msg. #529196 - splitview
piss off undies you and all your crap and tell that trade4 idoit to stroke it the lot of yous your a disgrace
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:29 - 236 reads
Posted by bigdump
IP 210.49.xxx.xxx
Post #529199 - in reply to msg. #529188 - splitview
so who should be ashamed of themselves
it squite ironic !
Isn't talking to ones self a form of madness
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:30 - 246 reads
Posted by diatribe
IP 203.51.xxx.xxx
Post #529201 - in reply to msg. #529199 - splitview
fark u 2 fool ramper
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:35 - 242 reads
Posted by trade4profit
IP 144.139.xxx.xxx
Post #529204 - in reply to msg. #529197 - splitview
diatribe...
Here are the posts you refer to "6 - 8 weeks ago"...
---
Subject copper strike.. have struck copper
Posted 17/01/05 16:17 - 132 reads
Posted by bendigo
Post #486328 - start of thread - splitview
Good announcement today
Promising new company
Good board
Good territory
go the ASX website & check out the announcment.
Cheers
Bendigo
---
Subject re: copper strike.. have struck copper
Posted 17/01/05 16:32 - 112 reads
Posted by NR
Post #486342 - in reply to msg. #486328 - splitview
all ready on them bendigo......awaiting further annonucements.......
---
Subject re: copper strike.. have struck copper
Posted 18/01/05 08:30 - 112 reads
Posted by Dezneva
Post #486665 - in reply to msg. #486328 - splitview
Yep, I agree. I know the people as well. They have a whole heap of old TEC ground. Its a great hit. and I think they are continuing the drilling.
---
These were the first 3 posts ever on CSE.
Although Dezneva only posted "...I know the people as well...", I can see how you may have remebered that as "...the boss being a good bloke..."
Problem is, it was Bendigo he was replying to and not you!
How do you explain that?
Cheers!
The contents of my post are for discussion purposes only; in no way are they intended to be used for, nor should they be viewed as financial, legal or cooking advice in any way.
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:40 - 234 reads
Posted by Rocker
IP 220.253.xxx.xxx
Post #529215 - in reply to msg. #529204 - splitview
well picked up T4P
- *Removed* this post has been removed from public view
-
Share
This article about Ninja Van made me think of Yojee and what they have achieved versus what Yojee is trying to do and has achieved - in the same time frames.
https://www.cnbc.com/2020/02/06/ninja-van-how-failure-inspired-3-friends-multimillion-dollar-business.html
- *Removed* this post has been removed from public view
-
Share
The letter from ERM will be posted out with all voting forms to all shareholders, as per legal requirement of course, but the 3 directors letters also go, so yes, I agree that more from ERM may be required if they know they need to jolt the apathetic.
Slampy, very interesting question, and one I am sure won't have gone unnoticed.
Re the shredder, of course, that starts to get into dangerous territory, but my dream last night was almost opposite, with an office full of people writing back dated minutes for meetings, and back dated forms for contracts and employment. It was a hectic dream, and I hope there's no reality in it at all.
- *Removed* this post has been removed from public view
-
Share
Merck paid a 75% premium to acquire Prometheus. The share price consequently rose from US$114 to US$193 – a rise of 70%.
A bigger lift in share price was seen in early December when Prometheus announced highly successful efficacy and safety results for one of its drugs in Phase 2 clinical trials of the two most common types of IBD – ulcerative colitis and the other in Crohn’s disease. The share price consequently rose from US$36 to US$117 over 2 days – a rise of 325%.
The same drug (PRA023, an anti-TL1A monoclonal antibody) is also being tested in a 100 patient Phase 2 trial in systemic sclerosis associated with interstitial lung disease. That trial is due for completion in 12 months.
A second drug is being tested in a 190 patient Phase 1 trial in IBD, with results due in Q4 this year.
Prometheus has a further 3 preclinical drugs in the pipeline.
Beyond IBD, Prometheus’ potential target diseases includes autoimmune disorders such as rheumatoid arthritis, atopic dermatitis and psoriasis.
Prior to the PRA023 Phase 2 results in December 2022, Prometheus had a market cap of US$1.6bn. At IPO in March 2021, the market cap was US$707m. Company spend in 2022 was US$123m. With Phase 2 results, Prometheus also announced a capital raise for US$500m. At year end, the company had ~US$700m of cash and securities.
While there are some existing treatments for ulcerative colitis and Crohn’s disease, many patients don’t respond and the treatments also pose long term safety concerns. None of the current treatments cure the disease and patients often require life-long treatment.
The addressable market population for IBD is large. Ulcerative colitis and Crohn’s disease together are estimated to affect over 5 million people globally. The IBD market is worth approximately US$18 billion globally and is estimated to grow to approximately US $49 billion globally by 2030.
Other than its clinical and preclinical assets, which address highly lucrative markets, Prometheus has a highly valuable discovery engine platform. This includes an extensive clinical database and associated biobank which is one of the world’s largest collections of biospecimens from patients suffering from IBD and other GI disorders. The database and biobank is exclusively licensed from Cedars-Sinai Medical Center and includes more than 200,000 samples linked to extensive clinical data from over 20,000 patients collected over more than 20 years.
Prometheus has promoted the fact that utilizing genetics-based precision medicine increases its probability of success. Its Prometheus360 platform enables the company to both select drug targets genetically associated with diseases and to develop genetic-based diagnostics designed to identify patients more likely to respond favourably to the therapies they are developing.
Merck is now in a race with Pfizer, which teamed up with Roivant mid last year to form Priovant Therapeutics. Successful results for Priovant’s own anti-TL1A antibody in a Phase 2 trial in ulcerative colitis, announced in January this year, will see both companies soon enter large Phase 3 trial in ulcerative colitis.
My observations…
With 2 completed Phase 2 trials, 1 ongoing Phase 2 trial, one large Phase 1 trial due to report this year and a further 3 preclinical drugs in development, Prometheus is well advanced on PYC.
Big indications = big trials = big money. Note the A$183 m costs for Prometheus last year and the A$745m recent cap raise. Just not possible for a clinical stage biotech in Australia.
Big indications = big attention + big competition. Autoimmune disease and inflammation are currently hot areas of interest for pharma, especially big pharma. That means red-hot competition between multiple well-resourced pharmas. As well as competing in late stage trials in ulcerative colitis against Roivant (Pfizer), Merck will also be up against AbbVie and Eli Lilly. Then there are the ~ 20 assets in clinical development for ulcerative colitis, including ones being developed by Amgen, Astra Zeneca, Bristol Myer Squibb, Boehringer, Gilead, J & J, and Novartis. While PYC’s smaller market indications may draw little initial attention, they also attract little competition. There is no current competition in RP11, PYC’s lead indication.
Don’t underestimate the importance and potential value of discovery engine platforms. Merck certainly didn’t. Once the first asset to come out of that platform is proven in clinical trials, the value of the entire pipeline is rerated.
As Prometheus was keen to promote, utilizing genetics-based precision medicine increases the probability of success. Where have I heard that before?
In summary, PYC is still a long way from the US$10bn league and doesn’t have the kind of blockbuster indications that attract investor and pharma attention. Nor is it likely to ever have the kind of funds needed to compete in the blockbuster indication space.
But PYC cleverly leverages what resources it does have to maximum effect. It is focusing first on monogenic orphan diseases (to contain costs and increase probability of success). It is playing to its strengths (a proprietary library, mined for cell-penetrating peptides that offer superior drug delivery; Prof. Sue Fletcher, a world-class scientific leader in PPMO antisense development; access to both the world- class expertise in retinal disease at the Lions Eye Institute and the Australian Inherited Retinal Diseases Registry and DNA databank which was established almost 40 years ago.) -
Share
CODis my pick as email has just been received from HC on behalf of next Oil Rush, detailing some good information.
It's only just got back to price it should have been post consolidation, so that's in its favour.
Very little to sell, I like that, as it will move quickly.
Many won't have received the email yet as they're at work, etc.
Read more here.
http://www.nextoilrush.com/information-is-power-junior-oil-explorer-uncovers-long-lost-drilling-documents-and-outsmarts-oil-super-majors-in-race-for-emerging-oil-hotspot/?utm_source=HCMO
Looks good for next week. Be prepared!- *Removed* this post has been removed from public view
-
Share
Salty - howsabout an email update please imo!!- *Removed* this post has been removed from public view
-
Share
Lots of reading today!
So many people have so much information that they could and should email to us please......
[email protected]
- *Removed* this post has been removed from public view
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.13 |
Change
-0.020(1.74%) |
Mkt cap ! $659.0M |
Open | High | Low | Value | Volume |
$1.17 | $1.19 | $1.13 | $187.3K | 162.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5698 | $1.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.15 | 938 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5698 | 1.130 |
1 | 889 | 1.125 |
1 | 41479 | 1.120 |
4 | 84261 | 1.100 |
1 | 2000 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.150 | 938 | 1 |
1.160 | 681 | 1 |
1.180 | 10000 | 1 |
1.200 | 25749 | 4 |
1.205 | 2270 | 1 |
Last trade - 16.10pm 19/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
RML
RESOLUTION MINERALS LTD
Craig Lindsay, In-Country CEO
Craig Lindsay
In-Country CEO
SPONSORED BY The Market Online